Author(s):
Pallavi Bhilaji Jire, Shrutika Krishnadas Patil, Nilesh Gulab Ahire, Mansi A. Dhankani, Amitkumar R. Dhankani, Sunil P. Pawar
Email(s):
pallavijire06@gmail.com , skpatil2323@gmail.com
DOI:
10.52711/0975-4377.2025.00021 
Address:
Pallavi Bhilaji Jire, Shrutika Krishnadas Patil, Nilesh Gulab Ahire, Mansi A. Dhankani, Amitkumar R. Dhankani, Sunil P. Pawar
P.S.G.V.P Mandal’s College of Pharmacy, Shahada, Maharashtra, India.
*Corresponding Author
Published In:
Volume - 17,
Issue - 2,
Year - 2025
ABSTRACT:
Liquisolid compacts represent a promising technology for improving the dissolution and bioavailability of poorly water-soluble drugs. Pharmaceutical scientists face significant challenges in formulating such drugs, as many newly discovered active pharmaceutical ingredients (APIs) exhibit solubility issues that hinder their absorption in the gastrointestinal tract. Liquisolid systems convert liquid pharmaceutical formulations into dry, free-flowing, and compressible powders by mixing non-volatile solvents with carrier and coating materials. Liquisolid Tablets offer a unique advantage for the formulation of poorly soluble drugs by enhancing dissolution and bioavailability. Compared to other drug delivery systems, they are cost-effective, easy to manufacture, and provide a stable, solid dosage form with the solubility advantages of liquids. Liquisolid tablets are especially beneficial for large-scale production, where other systems like soft gelatin capsules or nanosuspensions may be more costly and complex to produce. Liquisolid systems can be classified into powder drug solutions, powder drug suspensions, and powder liquid drugs, with further classification based on the formulation technique into Liquisolid compacts and microsystems. The main components include carrier materials, coating materials, non-volatile solvents, disintegrants, and lubricants. Despite the advantages, such as improved dissolution rates and controlled drug release, the technology is limited to water-insoluble drugs and may face challenges when dealing with high-dose formulations. This review discusses the preparation, formulation, advantages, disadvantages, and various evaluation techniques employed in Liquisolid compacts, offering insights into their potential for enhancing drug delivery and bioavailability.
Cite this article:
Pallavi Bhilaji Jire, Shrutika Krishnadas Patil, Nilesh Gulab Ahire, Mansi A. Dhankani, Amitkumar R. Dhankani, Sunil P. Pawar. Liquisolid Compact Tablet: An Innovative Approach for Enhancing Bioavailability and Solubility. Research Journal of Pharmaceutical Dosage Forms and Technology. 2025; 17(2):143-8. doi: 10.52711/0975-4377.2025.00021
Cite(Electronic):
Pallavi Bhilaji Jire, Shrutika Krishnadas Patil, Nilesh Gulab Ahire, Mansi A. Dhankani, Amitkumar R. Dhankani, Sunil P. Pawar. Liquisolid Compact Tablet: An Innovative Approach for Enhancing Bioavailability and Solubility. Research Journal of Pharmaceutical Dosage Forms and Technology. 2025; 17(2):143-8. doi: 10.52711/0975-4377.2025.00021 Available on: https://rjpdft.com/AbstractView.aspx?PID=2025-17-2-9
REFERENCE:
1. Kapsi, S.G; Ayreys, J.W. Processing Factors in Development of Solid Solution Formulation of Itraconazole for Enhancement of Drug Dissolution Behavior of Water Insoluble Drugs. J. Pharm. Sci. 2001; 76: 744-752.
2. Aguiar, A. J.; Zelmer, A.J.; Kinkel, A.W. Deagglomeration Behavior of relatively insoluble benzoic acid and its sodium salt. J. Pharm. Sci. 1979; 56: 1243-1252.
3. Finholt, P.; Solvang, S. Dissolution kinetics of drugs in human gastric juice the role of surface tension. J. Pharm. Sci. 1968; 57: 1322-1326.
4. Lin, S. L.; Menig, J.; Lachman, L. Interdependence of Physiological surfactant and drug particle size on the Dissolution behavior of water insoluble drugs. J.Pharm. Sci. 1968; 57: 2143-2146.
5. Ebert, W. R. Soft gelatin capsules: unique dosage form. Pharm. Tech. 1977; 1: 44-50.
6. K.D Tripathi. Introduction, Routes of Drug Administration; A look of Essential of Medical Pharmacology. Eighth Edition; 2018; Page no. 1-14.
7. Ashish P. Gorle, Shubham S. Chopade. Liquisolid Technology; Preparation, Characterization and Applications; Journal of Drug Delivery & Therapeutics 2020; Volume 10 Issue- 3; Page No. 295-307.
8. SV Phoke, A.D Hatkar, S.S Jaybhaye. Improvement of Solubility and Dissolution by Liquisolid Compact. Journal of Pharmaceutical Care & Health Systems. 9(1): 1-6.
9. Tanzeel Majeed, Mohd. Iqbal Bhat, Ganesh N. S. and Vineeth Chandy. Review on Liquisolid Compact Technique. World Journal of Pharmaceutical and Life Sciences. 2020; 6(4): 72-80.
10. Balaji A, Umashankar MS, B. Kavitha B. Et al. Liquisolid technology- A latest Review. International Journal of Applied Pharmaceutics. 2014; 6(1): 11-9.
11. Göke K, Lorenz T, Repanas A, Schneider F, Steiner D, Baumann K, et al. Novel Strategies for the formulation and Processing of poorly water-soluble drugs. Eur J Pharm Biopharm. 2018; 126: 40–56.
12. Bertoni S, Hasa D, Albertini B, Perissutti B, Grassi M, Voinovich D, Passerini N. Better and greener: sustainable pharmaceutical manufacturing Technologies for highly bioavailable solid Dosage forms. Drug Deliv Trans Res. 2022; 12(8): 1843–1858.
13. Sharma A, Jain CP. Techniques to enhance solubility of poorly soluble drugs: a review. J. Global Pharm. Tech. 2010; 2: 18-28.
14. Javadzadeh Y, Siahi MR, Asnaashari S, Nokhodchi A. An investigation of physicochemical properties of piroxicam Liquisolid compacts. Pharm. Dev. Technol. 2007; 12: 337-43.
15. Saharan VA, Kukkar V, Kataria M, Gera M. Choudhury, P.K. Dissolution enhancement of drugs. Part II: effect of Carriers. Int. J. Health Res. 2009; 2:207-23.
16. Spireas S, Sadu S. Enhancement of prednisolone dissolution properties using liquisolid compacts. Int. J. Pharm. 1998; 166: 177-88.
17. Martin, A. N.; Swarbbrick, J; Cammarata, A. Physical pharmacy; Philadelphia: Lea & Febiger, 1983. P.445-468.
18. Spireas, S. S.; Jarowski, C.I.; Rohera, B.D. Powder Solution technology: principles and mechanism. Pharm. Res. 1992; 9: 1351-1358.
19. Javadzadeh Y, Shariati H, Movahhed-Danesh E, Nokhodchi A. Liquisolid technique as a tool for enhancement of poorly water-soluble drugs. J Pharm Pharmacol. 2007; 59(6): 795-804.
20. Bolton S, Bon C. Pharmaceutical Statistics: Practical and Clinical Applications. CRC Press. 2004.
21. Aulton ME. Pharmaceutics: The Science of Dosage Form Design. Churchill Livingstone. 2002.
22. Lachman L, Lieberman HA, Kanig JL. The Theory and Practice of Industrial Pharmacy. Lea & Febiger. 1987.
23. Pingtian D, Dongkai W, Mei L, Haonan X, Jingzheng J, Xiao C, et al. Liquisolid technique and its applications in pharmaceutics. Asian J Pharm Sci. 2016; 9: 1-9.
24. Savkare AD, Bhavsar MR, Gholap VD, Kukkar PM. Liquisolid Technique: A Review. Int. J. Pharm. Sci. Res. 2017; 8(7): 2768–2775.
25. Lakshmi Sai PD, Sivaiah KV, Bonthagarala B, Rao PV. Review on liquisolid compact technology. World J. Pharm. Res. 2015; 4(2): 293–306.
26. Suryawanshi VK, Gidwani B, Verma A, Dubey N, Kaur CD. Formulation and Evaluation of Ramipril Liquisolid Compact Using Novel Carrier. Int. J. Pharm. Sci. & Res. 2019; 10(2): 917–925.
27. Patel DS, Pipaliya RM, Surti N. Liquisolid Tablets for Dissolution Enhancement of a Hypolipidemic Drug. Indian J. Pharm. Sci. 2015; 77(3): 290–298.
28. Nagamani H. B, Ganesh N. S. and Vineeth Chandy. Liquisolid Technique: A Novel Approch to Enhance Solubility. World Journal of Pharmaceutical Research. 2019; 8(13): 751-764.
29. Manisha Rokade, Pradnya Khandagale, Dipti Phadtare. Liquisolid Compact Techniques: A Review. International Journal of Current Pharmaceutical Research. 2018; 10(4): 1-5.
30. Mei Lu, Haonan Xin, Jingz heng Jiang, Xiao Chen, Tianzhi Yang, Dongkai Wang, Pingtian Ding. Liquisolid technique and its applications in pharmaceutics. Asian Journal of Pharmaceutical Sciences. 2017; 12: 115–123.
31. Daniel Ekpa Effiong, Godswill Chukwunweike Onunkwo. Principles, Applications and Limitations of the Liquisolid System of Drug Delivery: A Review. Trends in Medical Research. 2024; 19(1): 178-198.
32. Vinayak Mastiholimath, Nisha S. Shirkoli, Rachana Sambargi and Pallavi Chiprikar. Solubility Enhancement of Labetalol Hydrochloride by Using Liquisolid Technique for Management of Hypertension. International Journal of Pharmaceutical Sciences and Research. 2022; 13(12): 5080-5089.
33. Zainab E. Jassim. Formulation and Evaluation of Furosemide Liquisolid Compact. International Journal of Applied Pharmaceutics. Int J App Pharm. 2017; 9(6); 39-48.
34. Mir-Ali Molaei, Karim Osouli-Bostanabad, Khosro Adibkia, Javad Shokri, Solmaz Asnaashari, Yousef Javadzadeh. Enhancement of Ketoconazole Dissolution Rate by The Liquisolid Technique. Acta Pharm. 2018; 68: 325–336.
35. Asma A. Mokashia, Snehalata L. Gaikwad. Formulation and Evaluation of Liquisolid Compacts of Lornoxicam. Int J Pharm Pharm Sci. 11(6): 33-37.
36. Chella, N., N. Shastri and R.R. Tadikonda. Use of the liquisolid compact technique for improvement of the dissolution rate of valsartan. Acta Pharm Sin. 2012; B(2): 502-508.
37. Korni, R.D. and C.S.R. Gonugunta. Olanzapine liquisolid tablets using kolliphor el with improved flowability and bioavailability: In vitro and In vivo characterization. Turk. J. Pharm. Sci. 21: 52-61
38. Ramya Sri Sura, CVS Subrahmanyam, Shyam Sunder Rachamalla. Design and Evaluation of Liquisolid Compacts of Nebivolol Hydrochloride. Int J App Pharm. 2022; 14(2): 293-307.
39. Bhushan Rajendra Rane, Dnyaneshwar Sopan Gaikwad, Ashish Suresh Jain, Prashant Lakshaman Pingale, Nayan Ashok Gujarathi. Enhancement of Pioglitazone Hydrochloride Solubility Through Liquisolid Compact Formulation Using Novel Carrier Neusilin US 2. Pharmacophore. 2022; 13(3): 64-71.